Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nir Qvit

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of the American Heart Association|September 28, 2016
Transient Receptor Potential Vanilloid 1 Regulates Mitochondrial Membrane Potential and Myocardial Reperfusion InjuryCarl M Hurt, Yao Lu, Creed M Stary, et al.
Computational and Structural Biotechnology Journal|July 21, 2025
Inhibiting MARCH5/Mfn2 signaling as an alternative strategy to protect cardiomyocytes from hypoxia-induced mitochondrial dysfunctionFaten Habrat Zoabi, Mulate Zerihun, Roy Lizarovich, et al.
Journal of Medicinal Chemistry|May 23, 2026
Mitigating Excessive Mitochondrial Fission Through the Development of a Selective Macrocyclic Inhibitor Targeting Fis1/Mid51 SignalingMulate Zerihun, Sayan Chakraborty, Ayetenew Abita, et al.
Nature|November 8, 2016
Correcting mitochondrial fusion by manipulating mitofusin conformationsAntonietta Franco, Richard N Kitsis, Julie A Fleischer, et al.
Nature Communications|April 3, 2024
Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in ratsJulio C B Ferreira, Juliane C Campos, Nir Qvit, et al.
Nature Communications|January 20, 2019
A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in ratsJulio C B Ferreira, Juliane C Campos, Nir Qvit, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 8, 2016
Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitorsNir Qvit, Deborah Schechtman, Darlene Aparecida Pena, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of the American Heart Association|September 28, 2016
Transient Receptor Potential Vanilloid 1 Regulates Mitochondrial Membrane Potential and Myocardial Reperfusion InjuryCarl M Hurt, Yao Lu, Creed M Stary, et al.
Computational and Structural Biotechnology Journal|July 21, 2025
Inhibiting MARCH5/Mfn2 signaling as an alternative strategy to protect cardiomyocytes from hypoxia-induced mitochondrial dysfunctionFaten Habrat Zoabi, Mulate Zerihun, Roy Lizarovich, et al.
Journal of Medicinal Chemistry|May 23, 2026
Mitigating Excessive Mitochondrial Fission Through the Development of a Selective Macrocyclic Inhibitor Targeting Fis1/Mid51 SignalingMulate Zerihun, Sayan Chakraborty, Ayetenew Abita, et al.
Nature|November 8, 2016
Correcting mitochondrial fusion by manipulating mitofusin conformationsAntonietta Franco, Richard N Kitsis, Julie A Fleischer, et al.
Nature Communications|April 3, 2024
Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in ratsJulio C B Ferreira, Juliane C Campos, Nir Qvit, et al.
Nature Communications|January 20, 2019
A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in ratsJulio C B Ferreira, Juliane C Campos, Nir Qvit, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 8, 2016
Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitorsNir Qvit, Deborah Schechtman, Darlene Aparecida Pena, et al.
Pageof 5